Vestergaard
Vestergaard

Welcome to
Vestergaard USA!

American Innovation for Global Health and Prosperity

Saving Lives

up to 75  %

reduction in malaria cases over 3 years with dual active-ingredient mosquito nets—powered by US-backed innovation

Driving Prosperity

$ 4  trillion

economic opportunity linked to malaria elimination—described as “America’s highest-return African deal”

Fueling Innovation

$ 387  billion

projected economic impact from US-led research and development for global health

    Alt text not present

    US Innovation is Saving Lives

    Over a decade of partnerships in more than 20 states, and investment in American research, continue to advance technologies that protect health and drive economic growth.

    Learn more
    Alt text not present

    Advanced Textile Technology

    Polymer and insecticidal technology turn engineered fabrics into life-saving tools—each design combines durability and efficacy to protect communities for years.

    Learn more
    Alt text not present

    Our Unique “Double Dividend” Approach

    Innovation developed in the USA delivers a double dividend—saving lives globally while protecting livelihoods and economic resilience at home.

    Learn more
    Alt text not present

    Reducing Aid Dependency

    Aligned with US priorities, we help strengthen local capacity for health system ownership and build a self-sustaining future across Africa.

    Learn more

Malaria and Vector-Borne Diseases: A Health Threat to the USA

    30 US States

    Mosquito species that can carry malaria now reach across much of the country. Protecting our families, communities and workforce means staying ahead of these growing risks.

    2,000 Cases

    Thousands of malaria cases are brought into the USA annually by travellers, incurring over $60 million in yearly treatment costs—a reminder that once malaria returns it's costly to contain.

    Returned in 2023

    Eliminated from the USA back in 1951, locally acquired malaria resurfaced in 2023. Ongoing investment in innovation is essential to stamp out the disease everywhere and keep us all safe.

    9 New Pathogens

    Vector-borne diseases in the USA have more than doubled in the past 20 years, increasing the risk of infections like dengue and West Nile virus. Since 2004, nine new pathogens, including Zika, have also been identified.

About Vestergaard USA

Vestergaard USA is part of the Vestergaard Frandsen Group, which also includes US companies LifeStraw and Sceye. Vestergaard global headquarters are based in Switzerland. We are delivering real-world impact through American-led innovation, partnership, and commitment to a healthier, safer, and more prosperous United States.

Join us